Back to search
FDAFDA · Food and drugs·Recall number D-1436-2012

Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.

Published August 8, 2012 · Recall initiated: June 5, 2012

Summary

FDA records drug Class III recall D-1436-2012, published August 8, 2012 and initiated June 5, 2012. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 18,938 cartons; Lot: Lot #s: 412572A, 412572B, Exp 11/12. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Watson Laboratories Inc
Distributor
Nationwide.
Lot
Lot #s: 412572A, 412572B, Exp 11/12
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880. recalled?

Yes. FDA published recall D-1436-2012 on August 8, 2012. Reported hazard: Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.

What should I do if I have this product?

Voluntary: Firm initiated · Letter